-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bz0/+uAWQ7+nizHuVwIKyWwTwcitXCe13m1lqcLCnFcQOs19Dgkv4GhopST+lI0h 9X/e8kUnvl/JXvqjEN2Wjw== 0001193805-07-002168.txt : 20070821 0001193805-07-002168.hdr.sgml : 20070821 20070821085610 ACCESSION NUMBER: 0001193805-07-002168 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070806 FILED AS OF DATE: 20070821 DATE AS OF CHANGE: 20070821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHCARE ACQUISITION CORP CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2116 FINANCIAL CENTER STREET 2: 666 WALNUT STREET CITY: DES MOINES STATE: IA ZIP: 50309 BUSINESS PHONE: 515-244-5746 MAIL ADDRESS: STREET 1: 2116 FINANCIAL CENTER STREET 2: 666 WALNUT STREET CITY: DES MOINES STATE: IA ZIP: 50309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCleary Joel CENTRAL INDEX KEY: 0001409933 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 071069474 BUSINESS ADDRESS: BUSINESS PHONE: 410-269-2600 MAIL ADDRESS: STREET 1: C/O PHARMATHENE, INC STREET 2: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 3 1 e602489_ex.xml X0202 3 2007-08-06 0 0001326190 HEALTHCARE ACQUISITION CORP PIP 0001409933 McCleary Joel C/O PHARMATHENE, INC ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 1 0 0 0 Common Stock, $0.0001 par value per share 101411 D Stock Option (right to buy) 3.28 2004-09-11 2013-09-11 Common Stock 1671 D Stock Option (right to buy) 4.22 2007-01-18 2016-01-18 Common Stock 269 D 8% Convertible Notes 10.00 2007-08-03 2009-08-03 Common Stock 2670 D Received pursuant to the Agreement and Plan of Merger, dated as of January 19, 2007, among the Issuer, PAI Acquisition Corp., a Delaware Corporation and a direct wholly-owned subsidiary of the Issuer ("Merger Sub"), and PharmAthene, Inc., a privately held Delaware corporation ("Target"), whereby Merger Sub merged with and into Target as a result of which Target became a wholly-owned subsidiary of the Issuer (the "Merger"). 25% of the shares shall vest each year commencing on the first anniversary after the option grant dates of September 11, 2003 and January 18, 2006, respectively. Received in the Merger in exchange for existing stock options in the Target. Received in the Merger in exchange for existing convertible notes of the Target in the principal amount of $26,700 (plus accrued interest). /s/ Joel McCleary 2007-08-17 -----END PRIVACY-ENHANCED MESSAGE-----